A Boston University-led research team has come up with a breed of contrast agents that might open the door to the use of CT to noninvasively diagnose osteoarthritis. These agents visualize the distribution of glycosaminoglycans, the anionic sugars that account for the strength of joint cartilage.
A Boston University-led research team has come up with a breed of contrast agents that might open the door to the use of CT to noninvasively diagnose osteoarthritis. These agents visualize the distribution of glycosaminoglycans, the anionic sugars that account for the strength of joint cartilage.
Assessing local variations in glycosaminoglycans (GAGs) is necessary to diagnose cartilage disease like osteoarthritis, which afflicts more than 27 million in people in the U.S.
"Compared with commercially available contrast agents under the same experimental conditions, these new cationic agents are three times more sensitive for imaging cartilage," said Mark W. Grinstaff, Ph.D., a Boston University associate professor of chemistry and biomedical engineering who led the team.
Only tests on animal tissue have yet been done, but early results have been encouraging, particularly since current image quality with both MR and CT are subpar.
In a paper published earlier this year in the Journal of the American Chemical Society, Grinstaff and colleague Dr. Brian D. Snyder, an orthopedic surgeon at Children's Hospital Boston and an associate professor of orthopedic surgery at Harvard, describe the new contrast agents, which selectively bind to the GAGs in articular cartilage. This cartilage is found at the ends of bones in load-bearing joints such as knees, hips, and shoulders.
The loss of GAGs from these joints is the hallmark of osteoarthritis, a degenerative joint disease in which wear or trauma results in damage to the cartilage surface. Contrast agents currently in use with CT and MR rely on limited diffusion of the anionic, or negative ion-charged, contrast into the target tissue, the study noted.
The Boston research team reasoned that more sensitive imaging of this joint cartilage might be possible through the use of cationic contrast agents, which are electrostatically attracted to anionic GAGs. They focused on CT because this modality, with the new agent, could image cartilage and bone simultaneously, potentially enabling 3D reconstruction of the structure. The team synthesized three cationic, or positive ion-charged, iodine-based x-ray contrast agents.
Animal tests showed that the experimental agents produced better and more speci¬fic images for the cartilage tissue than the current negative ion-charged contrast agents. Snyder noted that the ability to acquire data about localized GAG content, morphology, and cartilage thickness on tissue samples may, in the future, aid in the diagnosis and treatment of osteoarthritis. Future safety testing will focus on determining toxicity levels of the agents and radiation dosage needed to produce diagnostic images.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.